Edgewell Personal Care (EPC) AI Stock Analysis

• Market Cap: $810.34M
• Dividend Yield: 3.51%
• Average Volume (3M): 800.44K
• Price to Earnings (P/E): 32.7
• Beta (1Y): 0.59
• Revenue Growth: -1.34%
• EPS Growth: -73.59%
• Country: US
• Employees: 6,700
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 0.68
• Shares Outstanding: 46,464,245
• 10 Day Avg. Volume: 775,628
• 30 Day Avg. Volume: 800,439
• PEG Ratio: -0.52
• Price to Book (P/B): 0.62
• Price to Sales (P/S): 0.43
• P/FCF Ratio: 23.36
• Enterprise Value/Market Cap: 2.63
• Enterprise Value/Revenue: 0.96
• Enterprise Value/Gross Profit: 2.31
• Enterprise Value/Ebitda: 11.50
• 1Y Price Target: $25.17
• Price Target Upside: 47.19% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 6
• EPS Forecast (FY): 2.36
• Revenue Forecast (FY): $2.26B

• Rating: 58 Neutral
• Price Target: $16.50 ▼(-3.51% Downside)

Edgewell Personal Care's overall stock score reflects a combination of mixed financial performance, bearish technical indicators, and a relatively high valuation. The company's strategic initiatives, such as the sale of the Feminine Care segment, provide a positive outlook. However, challenges in profitability, cash flow, and market sentiment weigh on the score. The earnings call and corporate events offer some optimism for future growth, but current market conditions and financial metrics suggest caution.

Positive Factors

Strategic Divestiture

The sale of the Feminine Care segment allows Edgewell to streamline its portfolio, focus on core categories, and strengthen its financial position, supporting long-term growth.

International Market Growth

Consistent international growth, particularly in Europe and Greater China, enhances Edgewell's global market position and diversifies revenue streams, contributing to long-term stability.

Productivity and Innovation

Productivity improvements and innovation in key regions strengthen operational efficiency and market competitiveness, supporting sustainable growth.

Negative Factors

Revenue Growth Challenges

Inconsistent revenue growth and recent declines highlight challenges in maintaining market momentum, which could impact long-term financial performance.

Declining Profit Margins

Declining profit margins due to external pressures could strain profitability, affecting Edgewell's ability to reinvest in growth and innovation.

Cash Flow Concerns

Negative free cash flow growth may limit Edgewell's capacity for future investments and debt servicing, posing a risk to financial flexibility and stability.

Edgewell Personal Care Business Overview & Revenue Model

Company Description

Edgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care. The Wet Shave segment provides razor systems, such as razor handles and refillable blades, and disposable shave products for men and women under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard, and Personna brands. The Sun and Skin Care segment provides general protection, sport, kids, baby, tanning and after sun products under the Banana Boat and Hawaiian Tropic brands, as well as antibacterial hand wipes, alcohol sanitizing wipes, and hand sanitizer gels under the Wet Ones brand; and skin care products for men under the Bulldog and Jack Black brands, and skin care and grooming products under the Cremo brand. The Feminine Care segment provides tampons under the Playtex Gentle Glide 360°, Playtex Sport, Playtex and o.b. brands; and markets pads and liners under the Stayfree and Carefree brands. The company was formerly known as Energizer Holdings, Inc. and changed its name to Edgewell Personal Care Company in June 2015. Edgewell Personal Care Company was founded in 1772 and is headquartered in Shelton, Connecticut.

How the Company Makes Money

Edgewell Personal Care generates revenue primarily through the sale of its branded consumer products across multiple categories. The company's key revenue streams include sales from its shaving products, which are a significant portion of its offerings, as well as its sun and skin care products, feminine care products, and infant care products. Edgewell benefits from its established brand recognition and consumer loyalty, which allows it to command premium pricing. Additionally, strategic partnerships with retailers and distributors enhance its market reach and visibility. The company also invests in marketing and product innovation to drive sales growth, adapting to evolving consumer preferences and trends, which further contributes to its overall earnings.

Edgewell Personal Care Financial Statement Overview

Summary

Edgewell Personal Care's financial statements present a mixed picture. The company demonstrates operational efficiency with positive EBIT and EBITDA margins, but faces challenges in revenue growth and profitability. The balance sheet is stable with a reasonable debt-to-equity ratio, yet declining return on equity raises concerns. Cash flow metrics highlight potential issues in cash generation and growth. While the company maintains a solid foundation, addressing the declining trends in profitability and cash flow will be crucial for future stability and growth.

Income Statement

Edgewell Personal Care's income statement reveals a mixed performance. The gross profit margin has slightly decreased over the years, indicating some pressure on cost management. The net profit margin has also declined, reflecting challenges in maintaining profitability. Revenue growth has been inconsistent, with a significant drop in the latest year. However, the company has managed to maintain a positive EBIT and EBITDA margin, which suggests operational efficiency. Overall, while there are strengths in operational margins, the declining revenue and net profit margins are areas of concern.

Balance Sheet

The balance sheet of Edgewell Personal Care shows a stable financial position with a manageable debt-to-equity ratio, indicating a balanced approach to leveraging. The return on equity has been declining, which may suggest challenges in generating returns for shareholders. However, the equity ratio remains healthy, reflecting a solid capital structure. The company appears to be maintaining a stable asset base, but the declining ROE is a potential risk factor.

Cash Flow

The cash flow analysis indicates some challenges for Edgewell Personal Care. The free cash flow growth rate has been negative recently, which could impact future investments and debt servicing. The operating cash flow to net income ratio is relatively low, suggesting that the company may face difficulties in converting its income into cash. However, the free cash flow to net income ratio remains positive, indicating some level of cash generation capability. Overall, while there are positive aspects, the declining free cash flow growth is a concern.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.22B	2.22B	2.25B	2.25B	2.17B	2.09B
Gross Profit	924.90M	924.90M	955.70M	940.80M	880.50M	951.20M
EBITDA	185.60M	185.60M	285.40M	317.60M	285.40M	302.10M
Net Income	25.40M	25.40M	98.60M	114.70M	99.50M	117.80M
Balance Sheet
Total Assets	3.76B	3.76B	3.73B	3.74B	3.71B	3.67B
Cash, Cash Equivalents and Short-Term Investments	225.70M	225.70M	209.10M	216.40M	188.70M	479.20M
Total Debt	1.41B	1.41B	1.39B	1.45B	1.46B	1.32B
Total Liabilities	2.20B	2.20B	2.15B	2.20B	2.25B	2.09B
Stockholders Equity	1.55B	1.55B	1.58B	1.54B	1.47B	1.58B
Cash Flow
Free Cash Flow	41.40M	41.40M	174.50M	166.60M	45.60M	172.20M
Operating Cash Flow	118.40M	118.40M	231.00M	216.10M	102.00M	229.00M
Investing Cash Flow	-72.90M	-72.90M	-62.40M	-50.50M	-355.40M	-48.70M
Financing Cash Flow	-30.00M	-30.00M	-179.40M	-146.50M	-17.60M	-65.40M

Edgewell Personal Care Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 17.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Negative. The current price of 17.1 is below the 20-day moving average (MA) of 17.28, below the 50-day MA of 18.14, and below the 200-day MA of 23.44, indicating a neutral trend. The MACD of -0.16 indicates Negative momentum. The RSI at 48.39 is Neutral, neither overbought nor oversold. The STOCH value of 23.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EPC.

Edgewell Personal Care Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CHD	72 Outperform	$20.52B	26.91	18.59%	1.38%	1.45%	42.04%
SPB	64 Neutral	$1.40B	15.55	4.92%	3.15%	-5.21%	1.96%
KMB	63 Neutral	$33.54B	17.12	136.87%	5.03%	-10.04%	-23.41%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
EPC	58 Neutral	$810.34M	32.68	1.62%	3.51%	-1.34%	-73.59%
NWL	49 Neutral	$1.54B	-61.64	-0.86%	7.76%	-5.88%	90.23%
COTY	49 Neutral	$2.68B	-6.73	-9.96%	―	-5.68%	-358.36%

Edgewell Personal Care Corporate Events

Edgewell Sells Feminine Care Segment to Essity

On November 12, 2025, Edgewell Personal Care announced an agreement to sell its Feminine Care segment to Essity for $340 million, aiming to streamline its portfolio and focus on core categories. This transaction, expected to close in early 2026, will allow Edgewell to strengthen its financial position and invest in long-term growth, while Essity plans to expand its presence in North America with this acquisition.